| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 37.254 | 98.718 | 115.173 | 137.946 | 158.011 | 166.446 | 173.064 | 229.204 | 285.215 | 328.720 |
| Total Income - EUR | 37.254 | 98.719 | 115.174 | 138.015 | 158.617 | 166.913 | 173.854 | 230.058 | 286.128 | 332.128 |
| Total Expenses - EUR | 36.508 | 73.568 | 91.065 | 96.140 | 114.521 | 117.040 | 133.039 | 155.806 | 205.118 | 221.289 |
| Gross Profit/Loss - EUR | 746 | 25.151 | 24.109 | 41.875 | 44.096 | 49.872 | 40.815 | 74.252 | 81.011 | 110.839 |
| Net Profit/Loss - EUR | -371 | 24.164 | 22.957 | 40.494 | 42.509 | 48.276 | 39.111 | 71.997 | 78.493 | 100.730 |
| Employees | 3 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 |
Check the financial reports for the company - Vero Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 24.263 | 20.655 | 18.013 | 17.778 | 16.595 | 12.785 | 52.677 |
| Current Assets | 4.154 | 24.770 | 29.571 | 44.507 | 89.367 | 138.696 | 76.710 | 65.544 | 117.538 | 75.217 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 213 |
| Receivables | 0 | 7.776 | 7.550 | 11.054 | 14.721 | 17.669 | 9.959 | 56.980 | 108.469 | 55.549 |
| Cash | 4.154 | 16.995 | 22.022 | 33.453 | 74.646 | 121.026 | 66.751 | 8.564 | 9.068 | 19.455 |
| Shareholders Funds | -4.135 | 20.115 | 23.054 | 63.125 | 104.412 | 150.709 | 86.406 | 72.087 | 118.440 | 100.818 |
| Social Capital | 45 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 8.290 | 4.656 | 6.518 | 5.645 | 5.610 | 6.000 | 8.082 | 10.052 | 11.882 | 27.077 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Vero Medica Srl